Short Interest in Cibus, Inc. (NASDAQ:CBUS) Increases By 5.8%

Cibus, Inc. (NASDAQ:CBUS - Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 2,360,000 shares, a growth of 5.8% from the December 31st total of 2,230,000 shares. Based on an average daily trading volume, of 165,400 shares, the days-to-cover ratio is currently 14.3 days. Approximately 12.1% of the shares of the company are sold short.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CBUS. FMR LLC boosted its stake in shares of Cibus by 16.9% during the third quarter. FMR LLC now owns 3,913,279 shares of the company's stock valued at $12,757,000 after purchasing an additional 566,328 shares in the last quarter. Wellington Management Group LLP acquired a new stake in Cibus during the 3rd quarter worth approximately $111,000. Charles Schwab Investment Management Inc. boosted its position in Cibus by 14.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company's stock worth $161,000 after buying an additional 6,276 shares during the period. State Street Corp increased its position in Cibus by 43.6% in the 3rd quarter. State Street Corp now owns 307,262 shares of the company's stock valued at $1,002,000 after acquiring an additional 93,236 shares during the period. Finally, Barclays PLC increased its position in Cibus by 287.2% in the 3rd quarter. Barclays PLC now owns 20,269 shares of the company's stock valued at $66,000 after acquiring an additional 15,034 shares during the period. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Cibus Stock Performance

Shares of CBUS remained flat at $2.52 during trading hours on Thursday. The stock had a trading volume of 97,955 shares, compared to its average volume of 152,348. Cibus has a 12 month low of $2.16 and a 12 month high of $23.18. The stock has a market capitalization of $66.68 million, a P/E ratio of -0.11 and a beta of 1.82. The business's fifty day simple moving average is $3.07 and its two-hundred day simple moving average is $4.65.

Cibus (NASDAQ:CBUS - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.89) by $0.95. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. The firm had revenue of $1.67 million during the quarter, compared to analysts' expectations of $0.47 million. During the same period in the prior year, the company earned ($1.59) earnings per share. Analysts expect that Cibus will post -2.96 EPS for the current fiscal year.

Analyst Ratings Changes

CBUS has been the topic of several research reports. Canaccord Genuity Group decreased their price target on shares of Cibus from $20.00 to $18.00 and set a "buy" rating on the stock in a research note on Wednesday, January 22nd. HC Wainwright restated a "buy" rating and set a $25.00 target price on shares of Cibus in a research report on Monday, November 11th.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.